0
Articles   |    
DOM (STP), a New Hallucinogenic Drug, and DOET: Effects in Normal Subjects
SOLOMON H. SNYDER; LOUIS A. FAILLACE; HERBERT WEINGARTNER
Am J Psychiatry 1968;125:357-364.
View Article Information
Associate professor, department of psychiatry and the behavioral sciences, and associate professor, department of pharmacology and experimental therapeutics, Johns Hopkins University School of Medicine, Baltimore, Md. 21205
Associate professor of psychiatry, Johns Hopkins University School of Medicine, Baltimore, Md. 21205
Assistant professor of medical psychology, department of psychiatry and the behavioral sciences, Johns Hopkins University School of Medicine, Baltimore, Md. 21205
1968-69, American Psychiatric Association
text A A A
PDF of the full text article.
Abstract
DOM, a hallucinogen related to mescaline and amphetamine and designated "STP" by hippies, along with DOET, the ethyl homologue of DOM, were given in small doses to normal subjects in a double-blind study. Both drugs increased self-awareness and produced mild euphoria but no hallucinogenic or psychotomimetic effects. The two drugs "freed up" subjects' word associations without impairing memory or concentration; in fact, DOM enhanced performance on serial learning tasks. Although DOM did not affect visual discrimination, it altered the perception of tachistoscopically presented TAT cards.Abstract Teaser
Figures in this Article

    Topics

    hallucinogen
    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    Books
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 15.  >
    The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 13.  >
    The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 14.  >
    The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 40.  >
    Psychiatric News
    PubMed Articles
    Clearing the smoke around medical marijuana.
    Clinical pharmacology and therapeutics 2011 Dec
    Cannabinoid-opioid interaction in chronic pain.
    Clinical pharmacology and therapeutics 2011 Dec